PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising

20 Dec 2013 07:00

RNS Number : 0319W
Byotrol PLC
20 December 2013
 



Byotrol plc

 

Fundraising

 

Byotrol plc ('Byotrol' or the 'Company'), the developer of anti-microbial hygiene technologies, is pleased to announce that it has today completed a fundraising of £380,000 (the 'Fundraising') by the issue of convertible loan notes ("Loan Notes") to new and existing investors in the Company. The proceeds of the Fundraising will be used to advance the restructuring of the group (as outlined in the Company's interim results released on 19 November 2013) and to support growth initiatives across the business.

 

The Loan Notes have a term of three years, are senior in ranking, unsecured and convertible at investors' option into ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 5.46p per Ordinary Share. The Loan Notes carry a coupon of 10% per annum, payable quarterly in arrears.

 

Based on the issue size of £380,000, the Loan Notes would, if converted, represent approximately 6,959,700 Ordinary Shares, amounting to 3.79% of the current issued share capital of the Company

 

The following directors of Byotrol plc have participated in the Fundraising:

 

Name

Loan Notes subscribed for

Number of Ordinary Shares to be issued if Loan Notes are converted

 

Existing number of Ordinary Shares held

Percentage holding following conversion of the Loan Notes

Ralph Kugler

£50,000

915,750

1,787,090

1.42%

David Traynor

£50,000

915,750

4,280,001

2.73%

Till Medinger

£30,000

549,450

593,854

0.60%

Nicholas Martel

£50,000*

915,750

**18,693,513

10.30%

 

* non-beneficial subscription

** includes a non-beneficial interest in 17,693,513 Ordinary Shares

 

Their participation constitutes a related party transaction for the purpose of the AIM Rules for Companies. The independent director of the Company, Duncan Grosvenor, having consulted with the Company's nominated adviser, finnCap, considers the terms of the Fundraising to be fair and reasonable insofar as the Company's shareholders are concerned.

 

Commenting on the fundraising, David Traynor, Chief Executive of Byotrol, said:

 

"These funds will allow us to further develop our plans to create a stronger Byotrol. We are currently performing to plan and are now able to start looking at growth from our new, leaner base. "

 

Enquiries:

 

Byotrol plc

01925 742000

David Traynor, Chief Executive

Duncan Grosvenor, Finance Director

finnCap Ltd

020 7220 0500

Nominated Adviser and broker

Geoff Nash/Christopher Raggett

Simon Starr (Corporate Broking)

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a leading anti-microbial technology company, operating globally in the Health, Food, Leisure, Consumer, Industrial and Agriculture sectors, providing a low toxicity product with a broad-based and long lasting efficacy across all microbial classes; bacteria, viruses, fungi, moulds and algae.

 

The Byotrol product can be used as a stand-alone product or as a complementary biocide additive to existing products to improve their performance in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Founded in 2005, the Company has prioritised the development of a technology that creates easier, safer and cleaner lives through partnering with providers of essential goods and services. Byotrol is the catalyst behind the aptly named global 'Hygiene Revolution'.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKCDNABDDKBD
Date   Source Headline
6th Apr 202010:56 amRNSHolding(s) in Company
2nd Apr 202011:05 amRNSSecond Price Monitoring Extn
2nd Apr 202011:00 amRNSPrice Monitoring Extension
24th Mar 20209:05 amRNSSecond Price Monitoring Extn
24th Mar 20209:00 amRNSPrice Monitoring Extension
23rd Mar 20207:01 amRNSTrading Update
23rd Mar 20207:00 amRNSLicence and Product Supply Agreement with Tristel
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
13th Mar 20202:05 pmRNSSecond Price Monitoring Extn
13th Mar 20202:00 pmRNSPrice Monitoring Extension
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20204:15 pmRNSHolding(s) in Company
30th Jan 20205:00 pmRNSDirector/PDMR Shareholding
30th Jan 20208:00 amRNSAcceleration of earn-out relating to Medimark
19th Dec 20197:00 amRNSInterim Results
14th Nov 201912:30 pmRNSResult of AGM
13th Nov 20197:00 amRNSHolding(s) in Company
8th Nov 20192:54 pmRNSHolding(s) in Company
11th Oct 20193:00 pmRNSRestoration - Byotrol Plc
11th Oct 20193:00 pmRNSPosting of Accounts, Notice of AGM and Restoration
1st Oct 20193:50 pmRNSHolding(s) in Company
1st Oct 20197:30 amRNSSuspension - BYOTROL PLC
30th Sep 201912:01 pmRNSPublication of accounts and temporary suspension
30th Sep 201912:00 pmRNSUnaudited Preliminary Results to 31 March 2019
25th Sep 20197:00 amRNSNotice of Results
3rd Sep 20199:08 amRNSNotice of Results
28th May 20197:00 amRNSAppointment of CFO & Award of Options
9th May 20197:00 amRNSTrading Update
15th Apr 201911:58 amRNSHolding(s) in Company
28th Feb 20197:00 amRNSEPA Approval and Target Roll-Out
31st Jan 20199:14 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSAppointment of New Director & Award of Options
31st Dec 20187:00 amRNSGrant of Options
21st Dec 20181:41 pmRNSHolding(s) in Company
21st Dec 20181:41 pmRNSHolding(s) in Company
20th Dec 201812:07 pmRNSDirector Dealings
18th Dec 20187:00 amRNSInterim Results
14th Nov 201810:35 amRNSHolding(s) in Company
13th Nov 20184:00 pmRNSHolding(s) in Company
13th Nov 201811:20 amRNSDirector/PDMR Shareholding
12th Nov 20185:05 pmRNSHolding(s) in Company
21st Sep 20184:00 pmRNSResult of AGM
4th Sep 201811:15 amRNSPosting of Annual Report and Notice of AGM
3rd Sep 20184:48 pmRNSHolding(s) in Company
3rd Sep 20184:12 pmRNSHolding(s) in Company
24th Aug 201812:01 pmRNSDirector Dealing
24th Aug 20187:00 amRNSDirector Dealing
23rd Aug 201811:31 amRNSAcquisition of Medimark Scientific Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.